Hepatitis C virus-related liver damage is related to cold activation of complement

Journal of Clinical Gastroenterology

Volumn 25, Issue 3, 1997, Pages 529-534

  Nomura, Hideyuki ^a,c   Ogo, Tomonori ^a   Rikimaru, Nobuki ^a   Ueno, Sachio ^a   Kakuno, Tatsuya ^a   Okamoto, Osamu ^a   Shiraishi, Genji ^a   Kashiwagi, Seizaburo ^b  

^a Shin Kokura Hospital   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c Shin Kokura Hospital   (Japan)

Author keywords

Cold activation; Complement; Hepatitis C virus; Interferon; Liver damage

Indexed keywords

ALPHA INTERFERON; COMPLEMENT;

ADULT; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL DAMAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; COLD; COMPLEMENT ACTIVATION; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; CRYOGLOBULINS; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RHEUMATOID FACTOR; RNA, VIRAL;

EID: 0030681329     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199710000-00010     Document Type: Article

References (36)

1. Gewurz H. Nonimmune activation of C: two new phenomena. J Imunol 1973;111:305.
2. Glovsky MM, Alenty A. Coagulation related deficiencies of early components od C (C1, C4, C2) in human serum. J Immunol 1973;111:305-6.
3. Kondo M, Hosokawa K, Masuda M. Cold activation of complement. I. Presence of coagulation-related activator. J Immunol 1976;117:486-90.
4. Kitamura H, Nagaki K, Inai S. Cold activation of the classical complement pathway found in the patients with chronic liver diseases. J Immunol 1976;116:1738-9.
5. Inai S, Kitamura H, Fujita T, Kojima J, Nagaki K. Differences between plasma and serum complement in patients with chronic liver disease. Clin Exp Immunol 1976;25:403-9.
6. Kitamura H, Nagaki K, Inoshita K, Iida K, Inai S. The cold activation of the classical complement pathway: the cause of the differences between plasma and serum complement in liver cirrhosis. Clin Exp Immunol 1977;27:34-7.
7. Takemura S, Hotta T, Matsumura N, Yoshikawa T, Kondo M. Cold activation of complement. Arthritis Rheum 1982;25:1138-40.
8. Akagaki Y, Fujiwara Y, Nakanishi I, et al. The difference between serum and plasma complement activity in primary renal disease. Clin Nephrol 1980;14:75-80.
9. Atkinson JP, Gorman JC, Curd J, et al. Cold dependent activation of complement in systemic lupus erythematosus, a unique cause for a discrepancy between clinical and laboratory parameters. Arthritis Rheum 1981;24:592-601.
10. Choo QL, Kuo G, Weiner AJ, et al. Isolation of cDNA clone derived from a blood borne non-A non-B hepatitis genome. Science 1989;244:359-62.
11. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
12. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-5.
13. Misiani R, Bellavita P, Fenili D. Hepatitis C virus and cryoglobulinemia. N Engl J Med 1993;328:1121.
14. Marcellin P, Descamps V, Martinot-Peignoux M, et al. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology 1993;104:272-7.
15. Lunel F, Musset L, Cacoub P, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994;106:1291-300.
16. Sansonno D, Cornacchiulo V, Iacobelli AR, et al. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatohgy 1995;21:305-12.
17. Bichard P, Ounanian A, Girard M, et al. High prevalence of hepatitis C virus RNA in the supernatant and the cryoprecipitate of patients with essential and secondary type II mixed cryoglobulinemia. J Hepatol 1994;21:58-63.
18. Ueda K, Nakajima H, Nakagawa T, Shimizu A. The association between hepatitis C virus infection and in vitro activation of the complement system. Ann Clin Biochem 1993;30:565-9.
19. Ueda K, Nakajima H, Hakagawa T, Shimizu A. The association of complement activation at a low temperature with hepatitis C virus infection in comparison with cryoglobulin. Clin Exp Immunol 1995;101:284-7.
20. Tanaka K, Aiyama T, Imai J, et al. Serum cryoglobulin and chronic hepatitis C virus disease among Japanese patients. Am J Gastroenterol 1995;90:1847-52.
21. Akahane Y, Miyazaki Y, Naitoh S, et al. Cold activation of complement for monitoring the response to interferon in patients with chronic hepatitis C. Am J Gastroenterol 1996;91:319-27.
22. Davis G, Lau JY, Urdea MS, et al. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: Definition of the optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 1994;19:1337-41.
23. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-9.
24. Simmonds P, Alberti A, Alter HJ, et al. A propose system for the nomenclature of hepatitis C virus genotypes. Hepatology 1994;19:1321-4.
25. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
26. Mayer MM. Complement and complement fixation. In: Kabat EA, Mayer MM, eds. Experimental Immunochemistry. Illinois: Charles C Thomas, 1961;133.
27. Kitamura H, Inai S, Nagaki K. A simple procedure for the titration of total hemolytic complement activity-one point method. Jpn J Clin Chem 1983;12:143-7.
28. Pawlotsky JM, Fleury A, Choukroun V, et al. Significance of highly positive C22-3 "indeterminate" second generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third generation HCV RIBA. J Clin Microbiol 1994;32:1357-9.
29. Musset L, Diemert MC, Taibi F, et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992;38:798-802.
30. Koizumi K, Enomoto N, Kurosaki M, et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 1995;22:30-5.
31. Serfaty L, Chazouilleres O, Pawlotsky JM, et al. Interferon alpha therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology 1996;110:291-5.
32. Clifford BD, Donahue D, Smith L, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995;21:613-9.
33. Pawlotsky JM, Yahia MB, Andre C, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994;19:841-8.
34. Brouet JC, Clauvel JP, Danson F, et al. Biologic and clinical significance of cryoglobulins. Am J Med 1974;57:775-88.
35. Wong VS, Egner T, Elsey T, Brown D, Alexander GJM. Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 1996;104:25-31.
36. Mathews LP, Mentyka RA, Chambers SL, et al. Cole-dependent activation of complement: recognition, assessment, and mechanism. J Clin Immunol 1992;12:362-70.